Evidence map›Paper›PMID 38894738›Full record

ArticleFrontiers in endocrinology2024

Comparative analysis through propensity score matching in thyroid cancer: unveiling the impact of multiple malignancies.

Akram Al-Ibraheem, Ahmed Saad Abdlkadir, Dhuha Ali Al-Adhami, Egesta Lopci, Amal Al-Omari, Mahmoud Al-Masri, Yacoub Yousef, Nabeela Al-Hajaj, Issa Mohamad, Susanne Singer and 1 more

Abstract readComparative Study
In one paragraph

Article in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Diagnostic efficacy of [Discover oncology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Akram Al-IbraheemDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan.
Ahmed Saad AbdlkadirDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan.
Dhuha Ali Al-AdhamiDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan.
Egesta LopciNuclear Medicine Unit, IRCCS- Humanitas Clinical and Research Hospital, Rozzano, Milan, Italy.
Amal Al-OmariOffice of Scientific Affairs and Research (OSAR), King Hussein Cancer Center (KHCC), Amman, Jordan.
Mahmoud Al-MasriDepartment of Surgery, King Hussein Cancer Center (KHCC), Amman, Jordan.
Yacoub YousefDepartment of Surgery, King Hussein Cancer Center (KHCC), Amman, Jordan.
Nabeela Al-HajajDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan.
Issa MohamadDepartment of Radiation Oncology, King Hussein Cancer Center (KHCC), Amman, Jordan.
Susanne SingerInstitute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Centre Mainz, Mainz, Germany.
Gerasimos P SykiotisDepartment of Endocrinology, Diabetology and Metabolism, Vaud University Hospital Center (CHUV), Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The incidence of thyroid cancer is on the rise worldwide, with childhood exposure to radiation being the sole acknowledged catalyst for its emergence. Nonetheless, numerous other factors that may pose risks are awaiting thorough examination and validation. This retrospective study aims to explore the malignancies linked to thyroid cancer and contrast the survival rates of those afflicted with a solitary tumor versus those with multiple primary neoplasms (MPN). Methods: This retrospective study examined data from King Hussein Cancer Center (KHCC), Jordan. Among 563 patients diagnosed with thyroid cancer, 30 patients had thyroid malignancy as part of MPN. For a 1:3 propensity score-matched analysis, 90 patients with only a primary thyroid malignancy were also enrolled. Results: Hematologic and breast malignancies were among the most frequent observed cancers alongside thyroid neoplasm. Patients who had MPN were diagnosed at older age, had higher body mass index and presented with higher thyroglobulin antibody levels ( Conclusion: MPN correlates with a significantly altered survival outcome of thyroid cancer patients. The diagnosis of thyroid carcinoma at an older age, accompanied by elevated initial thyroglobulin antibody levels and a notable familial predisposition, may raise concerns about the potential occurrence of synchronous or metachronous tumors.

Indexed as

Neoplasms, Multiple PrimaryPropensity ScoreThyroid NeoplasmsAdultAgedFemaleFollow-Up StudiesHumansJordanMaleMiddle AgedPrognosisRetrospective StudiesSurvival Ratemultiple primary cancersmultiple primary malignanciesmultiple primary neoplasmsprognosissurvival analysisthyroid carcinoma

Identifiers

PMID38894738
PMCPMC11184125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.